Sellas Stock 346% Year Near Final REGAL Deaths Ahead
Sellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
Understanding the key principles of financial planning is essential. Discover how these principles can shape your financial decisions.
26,768 articlesSellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
Chipotle’s stock rebound from a recent malaise is taking shape as pricing discipline and menu changes attract more di...
Oil shocks tied to the Iran conflict threaten U.S. growth as prices rise. Analysts say a price threshold around $110 ...
In March 2026, Anduril landed a long-term Army contract valued up to $20 billion, moving defense tech from pilots to ...
Oil trades around the $100 barrel mark as investors seek safety. This piece identifies a top defensive ETF and explai...
Chevron’s CEO warned that oil prices are still too low given the ongoing Strait of Hormuz disruption. Markets have no...
Mosaic's Q3 2025 results spotlight a sharply growing Brazil business, with Brazil EBITDA up 190% year over year. Yet ...
Through the first three months of 2026, the stock market diverged: the S&P 500 fell, while smaller firms outperformed...
SWIFT is moving its blockchain-based cross-border settlement from pilot to production-scale, with a mid-2026 MVP and ...
Broadcom reports AI-related revenue more than doubles in the latest quarter, but the stock trades flat as investors w...
As Lumentum and Coherent rally, Onto Innovation could be the next optics supplier to gain. Analysts say the surge ref...
Even after a stellar quarter, Micron stock moved lower. This article reveals the secret reason micron stock traders a...